As the nation continues to confront the coronavirus outbreak, Blue Cross and Blue Shield (BCBS) companies are supporting patients, health care partners and communities with nearly $3 billion committed to the fight. Working with health, government and community leaders, BCBS companies are at the forefront of care when it matters most.
BCBS companies have enhanced access to coronavirus care by eliminating key costs and are ensuring that healthcare systems and physician practices have the financial and medical resources they need to treat patients now and after this pandemic.
Congress has allocated $175 BILLION in relief funds directly to HOSPITALS and HEALTHCARE PRACTIITIONERS.
Source: Centers for Medicare and Medicaid Services, “Fact Sheet: Expansion of the Accelerated and Advance Payments Program for Providers and Suppliers During COVID-19 Emergency”
Older adults, people with an underlying medical condition or those who are immunocompromised may be at a HIGHER RISK OF SERIOUS ILLNESS due to COVID-19.
Source: Centers for Disease Control and Prevention
Currently, there are more than 40 U.S. and 300 INTERNATIONAL clinical trials underway for COVID-19 therapies.
Source: U.S. Food and Drug Administration, “FDA Combatting COVID-19 with Therapeutics,” April 9, 2020.